Shipment and Revenue Recognition of Initial Order of Culture Supernatant Products to JENECELL
Filed with TSE · · 2 pages · English
Summary by 6ix AI
Healios KK has announced the completion of the shipment and revenue recognition for its initial order of culture supernatant products to JENECELL, marking a significant step in its commercial activities in regenerative medicine. Looking ahead, Healios plans to continue discussions with JENECELL regarding future orders and aims to explore additional applications for culture supernatant in various fields.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Healios KK
- Notice Regarding Shipment Timing of Initial Order of Culture Supernatant Products to JENECELL
- FY2026 Q2 Financial Results (Material)
- Healios Selected for the AMED “Project to Promote the Industrialization of Regenerative/Cell Medicine and Gene Therapy”
- Notice Regarding the Filing of a Counterclaim in Response to a Lawsuit Filed Against Healios
- Healios K.K. to Present at Jefferies Global Healthcare Conference
Follow Healios KK into a list and get an email when it puts out news.
Follow Healios KK